Abe Yoando Pharma president selected as first Japanese speaker at 2026 longevity conference

Verifying
  • Abe Yoando Pharma selected President Tomonari Abe for the Longevity Investors Conference 2026.
  • $8 trillion is the projected longevity market size by 2030.
  • 1731 marks the company’s founding as official physicians to the Matsudaira clan’s shogun.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.